Poseida Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...

Related Keywords

New York ,United States ,Johanna Mylet ,Alex Lobo ,Sarah Thailing ,Linkedin ,Twitter ,Corporate Communications ,Poseida Therapeutics Inc ,Nasdaq ,Poseida Therapeutics ,Chief Financial Officer ,Annual Global Investment Conference ,Media Section ,Site Specific Gene Editing System ,